Abstract: A floating carrier includes an embedded holder assembly provided in the floating carrier. The embedded holder assembly includes a holder and a framework structure. The holder has an opening at one end. This application further provides a floating body fixing unit, a floating body, and a method for installing the floating body. The floating body fixing unit includes a metal grid and the floating carrier mounted in the metal grid. The floating carrier is mounted in the metal grid through the holder with an opening at one end, through which a metal cable is placed in the fixator. The opening is closed by a bolt.

Abstract: An in-situ and in-operando internal state detecting system for an energy storage device comprises a first acoustic signal-emitting acoustic signal emission module, an interior-residing optical sensing module, and a first input optical signal-providing signal demodulation module. The optical sensing module receives a second acoustic signal when the first acoustic signal transmits inside the energy storage device, and outputs a first optical signal, which is demodulated and analyzed by the signal demodulation module to obtain acoustic feature information. Optionally, the signal demodulation module also provides a second input optical signal, and the optical sensing module outputs a second optical signal, which is analyzed by the signal demodulation modulation module to obtain optical feature information.

Abstract: The disclosure relates to selective small molecule dual activators of human constitutive androstane receptor (hCAR) and nuclear factor erythroid 2-related factor 2 (Nrf2), pharmaceutical compositions thereof, and use thereof for the treatment of hematologic malignancies and other cancers. The small molecule dual hCAR and Nrf2 activators in combination with CPA based chemotherapy regimen provides a synergistic effect to help promote cytoxicity of the cyclophosphamide (CPA) based and doxorubicin (DOX) based anticancer treatments including CHOP regimen (CPA, doxorubicin, vincristine, and prednisone) while reducing cardiotoxicity associated with DOX.

Abstract: The present invention provides improved devices for co-culture of cells. The devices include inserts having invertible wells that can be lowered into a well of any standard cell culture plate. A first population of cells can be cultured in the invertible wells of the inserts and a second population of cells can be cultured in the wells of a cell culture plate. Once the first population of cells attach to the invertible wells, the inserts are flipped over and placed into the wells of the cell culture plate to co-culture with the second population of cells.

Abstract: The present invention provides improved devices for co-culture of cells. The devices include inserts having invertible wells that can be lowered into a well of any standard cell culture plate. A first population of cells can be cultured in the invertible wells of the inserts and a second population of cells can be cultured in the wells of a cell culture plate. Once the first population of cells attach to the invertible wells, the inserts are flipped over and placed into the wells of the cell culture plate to co-culture with the second population of cells.